Discovery & Development

With regulators looking for more differentiation between tablets, we must be bolder with solid dosage designs.

Women’s health used to be considered solely in terms of maternal and reproductive health. Not anymore.

Aptar Pharma announces the re-launch of its Bag-on-Valve (BOV) activities in its Radolfzell manufacturing site

How can we overcome bioavailability challenges in our increasingly complex drug pipeline?

A new model for cocrystal formation could be a powerful tool for formulation scientists – no crystal structures required, it’s all about the surface contacts.

Making medicines for pediatrics adds a whole new dimension to the challenges of formulation and drug delivery

Electrochemical reaction cells are finding new applications in the pharma R&D lab that could offer big time and cost savings.

The days of “low-hanging fruit” in drug discovery are a thing of the past.

Could medicines be made more effective with better timing?

If I knew six years ago just how much of my time EXCiPACT would take up, would I have even started?